Although these two drugs were originally developed to improve glycemic control in people with type 2 diabetes, they simultaneously cause significant weight loss in these patients, without too many major side effects, and could therefore represent a new therapeutic strategy for the normalization of body weight
On Sept
MUFAs can inhibit the accumulation of ROS in the plasma membrane and reduce the binding of PUFAs to phospholipids, thereby mitigating oxidative processes and preventing ferroptosis [39]
R., Balasubramanian, R., Chauhan, R., Priyakumar, U
Persistent vomiting or diarrhoea can lead to dehydration, which in some cases may affect kidney function
But there are some reports that hint at how the drug may affect mental health in general